5 years experience administering intravenous vancomycin through a midline catheter

0

These outcomes summarize more than 5 years of experience administering intravenous vancomycin (4 mg/mL) safely and cost-efficiently through a nontrimmable midline catheter” Caparas and Hung (2017).

Abstract:

Background: The 2016 Infusion Therapy Standards of Practice no longer require that low pH (<5) medications be administered via central venous access devices. Nevertheless, the practice of placing PICCs for vancomycin administration often persists.

Purpose: To demonstrate the safety and efficacy of intravenous vancomycin administration through a short and long term midline catheter.

Methodology: A retrospective chart review was performed on 1086 patients who received intravenous vancomycin through a midline catheter.

Results: There were no catheter-associated bloodstream infections and no deep vein thromboses. Phlebitis occurred rarely (0.6%), as did benign infiltrations (1.2%). There were no extravasation injuries.

Conclusions: These outcomes summarize more than 5 years of experience administering intravenous vancomycin (4 mg/mL) safely and cost-efficiently through a nontrimmable midline catheter.

Full Text

Reference:

Caparas, J.V. and Hung, H-S. (2017) Vancomycin Administration Through a Novel Midline Catheter: Summary of a 5-Year, 1086-Patient Experience in an Urban Community Hospital. The Journal of the Association for Vascular Access. 22(1), p.38-41.

DOI: http://dx.doi.org/10.1016/j.java.2016.10.092

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.